Am J Nephrol. 2007;27(5):466-78. Epub 2007 Jul 25.

Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.

Source

Department of Orthopedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan. TANAKAS-ORT@h.u-tokyo.ac.jp

Erratum in

Am J Nephrol. 2007;27(5):544.

Abstract

Bone integrity is maintained through a balance between bone formation and bone resorption, and osteoclasts are primary cells involved in bone resorption. Recent studies have revealed an essential role of macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL) in the development of osteoclasts, and detailed molecular cascades that induce osteoclast differentiation, activation and apoptosis have been clarified. Osteoclasts are involved in various pathologic conditions, such as osteoporosis, rheumatoid arthritis and tumor-induced bone disease, which are characterized by abnormal bone resorption, and the finding of RANKL has provided us a good therapeutic target for such pathologic conditions.

2007 S. Karger AG, Basel

PMID:: 17652963; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Icon for S. Karger AG, Basel, Switzerland

Save items

Related citations in PubMed

Review Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors. [Assay Drug Dev Technol. 2006]
Review Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.
Chen T, Feng X. Assay Drug Dev Technol. 2006 Aug; 4(4):473-82.
Review Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. [Immunol Rev. 2005]
Review Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
Tanaka S, Nakamura K, Takahasi N, Suda T. Immunol Rev. 2005 Dec; 208:30-49.
Review Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. [Adv Exp Med Biol. 2009]
Review Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies.
Anandarajah AP, Schwarz EM. Adv Exp Med Biol. 2009; 649:85-99.
Review RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. [Adv Exp Med Biol. 2009]
Review RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies.
Leibbrandt A, Penninger JM. Adv Exp Med Biol. 2009; 649:100-13.
The RANKL/RANK/OPG pathway. [Curr Osteoporos Rep. 2007]
The RANKL/RANK/OPG pathway.
Boyce BF, Xing L. Curr Osteoporos Rep. 2007 Sep; 5(3):98-104.

See reviews... See all...

Cited by 4 PubMed Central articles

Review The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. [Nat Rev Endocrinol. 2009]
Review The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.
Razzaque MS. Nat Rev Endocrinol. 2009 Nov; 5(11):611-9.
Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. [J Clin Invest. 2009]
Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.
Kim H, Choi HK, Shin JH, Kim KH, Huh JY, Lee SA, Ko CY, Kim HS, Shin HI, Lee HJ, et al. J Clin Invest. 2009 Apr; 119(4):813-25. Epub 2009 Mar 2.
Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. [J Bone Miner Res. 2009]
Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia.
Nakajima A, Sanjay A, Chiusaroli R, Adapala NS, Neff L, Itzsteink C, Horne WC, Baron R. J Bone Miner Res. 2009 Jul; 24(7):1162-72.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK...
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.
Am J Nephrol. 2007 ;27(5):466-78. Epub 2007 Jul 25 .

PubMed
HLA class II genetic diversity in Arabs and Jews of Iran.
HLA class II genetic diversity in Arabs and Jews of Iran.
Iran J Immunol. 2007 Jun ;4(2):85-93.

PubMed
Changing patterns in the incidence and survival of thyroid cancer with follicula...
Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study.
Endocr Pathol. 2007 Spring ;18(1):1-7.

PubMed
Cloning and nucleotide sequence of the structural gene encoding for human trypto...
Cloning and nucleotide sequence of the structural gene encoding for human tryptophanyl-tRNA synthetase.
Gene. 1991 Dec 30 ;109(2):291-6.

PubMed
A role for notch signaling in human corneal epithelial cell differentiation and ...
A role for notch signaling in human corneal epithelial cell differentiation and proliferation.
Invest Ophthalmol Vis Sci. 2007 Aug ;48(8):3576-85.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.

Source

Erratum in

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information